Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

Clinical trial NCT07165132 · RECRUITING

Trial details

NCT number: NCT07165132
Sponsor: RayzeBio, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

GEP-NET Gastroenteropancreatic Neuroendocrine Tumor Gastroenteropancreatic Neuroendocrine Tumor Disease Neuroendocrine Tumors Carcinoid Carcinoid Tumor Pancreatic NET Solid Tumor Somatostatin Receptor

Start date: 2025-12-03
Primary completion: 2027-02-01
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.